| Effect of early versus deferred antiretroviral therapy for HIV on survival MM Kitahata, SJ Gange, AG Abraham, B Merriman, MS Saag, AC Justice, ... New England Journal of Medicine 360 (18), 1815-1826, 2009 | 1584 | 2009 |
| Competing risk regression models for epidemiologic data B Lau, SR Cole, SJ Gange American journal of epidemiology 170 (2), 244-256, 2009 | 1267 | 2009 |
| Deployment of convalescent plasma for the prevention and treatment of COVID-19 EM Bloch, S Shoham, A Casadevall, BS Sachais, B Shaz, JL Winters, ... The Journal of clinical investigation 130 (6), 2757-2765, 2020 | 936 | 2020 |
| Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America MJ Silverberg, B Lau, AC Justice, E Engels, MJ Gill, JJ Goedert, GD Kirk, ... Clinical infectious diseases 54 (7), 1026-1034, 2012 | 584 | 2012 |
| Selection bias due to loss to follow up in cohort studies CJ Howe, SR Cole, B Lau, S Napravnik, JJ Eron Jr Epidemiology 27 (1), 91-97, 2016 | 378 | 2016 |
| Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection G Chander, B Lau, RD Moore JAIDS Journal of Acquired Immune Deficiency Syndromes 43 (4), 411-417, 2006 | 373 | 2006 |
| Cumulative incidence of cancer among persons with HIV in North America: a cohort study MJ Silverberg, B Lau, CJ Achenbach, Y Jing, KN Althoff, G D'Souza, ... Annals of internal medicine 163 (7), 507-518, 2015 | 322 | 2015 |
| Exceeding the limits of liver histology markers SH Mehta, B Lau, NH Afdhal, DL Thomas Journal of hepatology 50 (1), 36-41, 2009 | 312 | 2009 |
| Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada JR Koethe, CA Jenkins, B Lau, BE Shepherd, AC Justice, JP Tate, ... AIDS research and human retroviruses 32 (1), 50-58, 2016 | 290 | 2016 |
| Importance of age of onset in pancreatic cancer kindreds KA Brune, B Lau, E Palmisano, M Canto, MG Goggins, RH Hruban, ... Journal of the National Cancer Institute 102 (2), 119-126, 2010 | 279 | 2010 |
| C-reactive protein is a marker for human immunodeficiency virus disease progression B Lau, AR Sharrett, LA Kingsley, W Post, FJ Palella, B Visscher, SJ Gange Archives of internal medicine 166 (1), 64-70, 2006 | 269 | 2006 |
| Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races GM Lucas, B Lau, MG Atta, DM Fine, J Keruly, RD Moore The Journal of infectious diseases 197 (11), 1548-1557, 2008 | 265 | 2008 |
| Early outpatient treatment for Covid-19 with convalescent plasma DJ Sullivan, KA Gebo, S Shoham, EM Bloch, B Lau, AG Shenoy, ... New England Journal of Medicine 386 (18), 1700-1711, 2022 | 254* | 2022 |
| Random survival forests for competing risks H Ishwaran, TA Gerds, UB Kogalur, RD Moore, SJ Gange, BM Lau Biostatistics 15 (4), 757-773, 2014 | 251 | 2014 |
| Association of race and gender with HIV-1 RNA levels and immunologic progression K Anastos, SJ Gange, B Lau, B Weiser, R Detels, JV Giorgi, JB Margolick, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 24 (3), 218-226, 2000 | 224 | 2000 |
| Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3 B Lau, SJ Gange, RD Moore JAIDS Journal of Acquired Immune Deficiency Syndromes 44 (2), 179-187, 2007 | 183 | 2007 |
| Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000–2010 K Buchacz, B Lau, Y Jing, R Bosch, AG Abraham, MJ Gill, MJ Silverberg, ... The Journal of infectious diseases 214 (6), 862-872, 2016 | 175 | 2016 |
| Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care RC Kalayjian, B Lau, RN Mechekano, HM Crane, B Rodriguez, RA Salata, ... Aids 26 (15), 1907-1915, 2012 | 167 | 2012 |
| Virologic and immunologic response to HAART, by age and regimen class KN Althoff, AC Justice, SJ Gange, SG Deeks, MS Saag, MJ Silverberg, ... Aids 24 (16), 2469-2479, 2010 | 159 | 2010 |
| Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy MJ Mugavero, S Napravnik, SR Cole, JJ Eron, B Lau, HM Crane, ... Clinical infectious diseases 53 (9), 927-935, 2011 | 157 | 2011 |
Catherine R. LeskoJohns Hopkins Bloomberg School of Public HealthVerified email at jh.edu
